KRISHNAMURTHY , Pramila

Last name: KRISHNAMURTHY

First name: Pramila

2021 (v1)

Publication

Metadata-only

Early and late-onset veno-occlusive disease/sinusoidal syndrome post allogeneic stem cell transplantation - a real-world UK experience

Mehra, Varun Tetlow, Simon Choy, Adrian

Classical veno-occlusive disease/sinusoidal obstruction syndrome (VOD/SOS) is a serious complication post allogeneic hematopoietic stem cell transplantation (HSCT). Before the recently revised EBMT criteria, the Baltimore and modified Seattle criteria failed to recognize the syndrome of late-onset VOD. We present real-world experience from a...

Uploaded on: February 11, 2024
2023 (v1)

Publication

Metadata-only

Fludarabine-Melphalan-Campath, Followed by Unmanipulated Peripheral-Blood Haematopoietic Stem Cells, Can Still Cure Lymphoma

Avenoso, Daniele Alabdulwahab, Amal Kenyon, Michelle

Background: The second decade of this millennium was characterized by a widespread availability of chimeric antigen receptor T-cell (CAR-T) therapies to treat relapsed and refractory lymphomas. As expected, the role and indication of allogeneic haematopoietic stem cell transplant (allo-HSCT) in the management of lymphoma changed. Currently, a...

Uploaded on: February 13, 2024
2022 (v1)

Publication

Metadata-only

Systematic screening and focused evaluation for veno-occlusive disease/sinusoidal obstructive syndrome (VOD/SOS) following allogeneic stem cell transplant is associated with earlier diagnosis and prompt institution of defibrotide treatment

Avenoso, Daniele Kenyon, Michelle Mehra, Varun

No description

Uploaded on: February 14, 2024
2023 (v1)

Publication

Metadata-only

Myeloablative dose of busulfan and fludarabine combined with in vivo T-cell depletion is a safe and effective conditioning for acute myeloid leukaemia and myelodysplastic syndrome patients

Avenoso, Daniele Mehra, Varun Slonim, Liron Barnea

Background: Allogeneic haematopoietic stem cell transplant (HSCT) is a curative strategy for acute myeloid leukaemia (AML) and myelodysplastic syndromes (MDS). The prediction of transplant related mortality (TRM) using the HCT-CI score and an arbitrary upper limit of 55 years for administering myeloablative conditioning (MAC) are common...

Uploaded on: February 13, 2024
2020 (v1)

Publication

Metadata-only

Poor outcome and prolonged persistence of SARS-CoV-2 RNA in COVID-19 patients with haematological malignancies; King's College Hospital experience

Shah, Vallari Ko Ko, Thinzar Zuckerman, Mark

No description

Uploaded on: February 14, 2024

KRISHNAMURTHY , Pramila

Recent uploads